HIV prevalence in dental outpatients in Brazil. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV prevalence in dental outpatients in Brazil.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):365-7. Unique Identifier : AIDSLINE MED/98007068
de Almeida OP; de Souza Filho FJ; Scully C; Line SR; Porter S; Department of Oral Pathology, Dental School of Piracicaba,; University of Campinas, Sao Paulo, Brazil.


Abstract: A series of dental outpatients in Brazil was anonymously screened for HIV antibodies in whole unstimulated saliva with an immunoglobulin G antibody-capture enzyme-linked immunosorbent assay. Salivary HIV antibodies were detected in 40 patients in the control group who were known to be HIV-seropositive but were not detected in any of a series of 40 known HIV-seronegative patients in the control group, confirming the very high sensitivity and specificity of the immunoglobulin G antibody-capture enzyme-linked immunosorbent assay. Only one patient from 84 consecutive dental outpatients of unknown HIV serostatus who were examined anonymously for HIV by immunoglobulin G antibody-capture enzyme linked immunosorbent assay showed HIV positivity (1.2% of the population).
Keywords: Adolescence Adult Ambulatory Care Blotting, Western Brazil/EPIDEMIOLOGY Dental Care Enzyme-Linked Immunosorbent Assay Female Human HIV Antibodies/ANALYSIS HIV Infections/*EPIDEMIOLOGY HIV Seronegativity HIV Seropositivity/*EPIDEMIOLOGY IgG/ANALYSIS Male Middle Age Prevalence Saliva/IMMUNOLOGY Sensitivity and Specificity JOURNAL ARTICLEKWDadolescenceadultambulatorycareblotting,westernbrazil/epidemiologydentalcareenzyme-linkedimmunosorbentassayfemalehumanhivantibodies/analysishivinfections/KWDepidemiologyhivseronegativityhivseropositivity/KWDepidemiologyigg/analysismalemiddleageprevalencesaliva/immunologysensitivityandspecificityjournalarticle
980228
M9820537

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .